| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 01/24/2008 | US20080020055 Phenylephrine Pharmaceutical Formulations and Compositions for Colonic Absorption |
| 01/24/2008 | US20080020025 Composition for wound care and method of using same |
| 01/24/2008 | US20080020018 Combination Products |
| 01/24/2008 | US20080020010 Pyridinone diketo acids: inhibitors of HIV replication |
| 01/24/2008 | US20080019999 Method of vaccinating subjects receiving immune modulating therapy |
| 01/24/2008 | US20080019994 Immunization Against Chlamydia Infection |
| 01/24/2008 | US20080019989 Immunity Adjuvant Containing a Complexed Metal Cation and Vaccine Containing Same |
| 01/24/2008 | US20080019988 Targeting of genetic vaccine vectors |
| 01/24/2008 | US20080019986 Methods of inhibiting binding of beta-sheet fibril to rage and consequences thereof |
| 01/24/2008 | US20080019985 Oxidative damage and protease activity resistance; catalytic efficiency; deep vein thrombosis, disseminated intravascular coagulation, acute coronary syndrome; targeting protein, that interacts with tissue factor or the factor VIIa/tissue factor complex |
| 01/24/2008 | US20080019979 HERV-K Antigens, Antibodies, and Methods |
| 01/24/2008 | US20080019976 The antibodies bind to whole bacteria and enhance phagocytosis and killing of the bacteria in vitro and enhance protection from lethal infection in vivo |
| 01/24/2008 | US20080019960 Use of alefacept aka AMVIVE (reg) to treat herpes, HIV, hepatitis, papillomavirus, Epstein-Barr virus, cytomegalovirus in humans; includes co-infected individuals |
| 01/24/2008 | US20080019955 Surface Protection of Exposed Biological Tissues |
| 01/24/2008 | US20080019950 Novel hepatocyte-like cells and hepatoblast-like cells derived from hBS cells |
| 01/24/2008 | US20080019945 Attenuation of Cytomegalovirus Virulence |
| 01/24/2008 | US20080019943 Broad spectrum immune and antiviral gene modulation by oral interferon |
| 01/24/2008 | US20080019942 Novel inhibitors of hepatitis c virus replication |
| 01/24/2008 | US20080019912 Glycoprotein 5 (GP5) and M protein of PRRSV linked by a disulfide bond gives rise to protective antigenic determinant (PAD polypeptide) that is used provide protection PRRSV; immunizing pigs |
| 01/24/2008 | DE10333245B4 Präbiotisch wirksame Pflanzenextrakte Prebiotic active plant extracts |
| 01/24/2008 | CA2777173A1 Improvement of the bioavailability of active substances having an amidine function in medicaments |
| 01/24/2008 | CA2658633A1 Chiral compounds substituted with phosphonic acid ester functions or phosphonic acid functions |
| 01/24/2008 | CA2658506A1 Acrymalide derivatives as fab 1 inhibitors |
| 01/24/2008 | CA2658261A1 Derivatives and analogs of n-ethylquinolones and n-ethylazaquinolones |
| 01/24/2008 | CA2657936A1 Antiviral protease inhibitors |
| 01/24/2008 | CA2657821A1 Aza-peptide protease inhibitors |
| 01/24/2008 | CA2657788A1 Polycyclic viral inhibitors |
| 01/24/2008 | CA2657723A1 Non-nucleoside reverse transcriptase inhibitors |
| 01/24/2008 | CA2656883A1 Identification, optimization and use of cryptic hla-b7 epitopes for immunotherapy |
| 01/24/2008 | CA2655623A1 Anti-nkg2a antibodies and uses thereof |
| 01/24/2008 | CA2653374A1 Modulators of pharmacokinetic properties of therapeutics |
| 01/23/2008 | EP1881075A1 Retroviral vectors having a reduced recombination rate |
| 01/23/2008 | EP1880997A1 Crystal of 1-methylcarbapenem compound |
| 01/23/2008 | EP1880735A2 Vaccine |
| 01/23/2008 | EP1880734A2 Multi-component vaccine to protect against disease caused by haemophilus influenzae and moraxella catarrhalis |
| 01/23/2008 | EP1880213A2 Silver/water, silver gels and silver-based compositions; and methods for making and using the same |
| 01/23/2008 | EP1879921A2 Host cell specific binding molecules capable of neutralizing viruses and uses thereof |
| 01/23/2008 | EP1879910A2 Tripeptides as hepatitis c virus inhibitors |
| 01/23/2008 | EP1879885A1 Heterocyclic antiviral compounds |
| 01/23/2008 | EP1879884A1 Azole-based phosphodiesterase inhibitors |
| 01/23/2008 | EP1879879A1 Compounds and methods for the treatment or prevention of flavivirus infections |
| 01/23/2008 | EP1879856A2 Alkyl-, alkenyl- and alkynyl carbamate derivatives, the preparation and therapeutic use thereof |
| 01/23/2008 | EP1879656A1 Pharmaceutical composition comprising an antiviral agent, an antitumoral agent or an antiparasitic agent, and an active agent selected among carveol, thymol, eugenol, borneol and carvacrol |
| 01/23/2008 | EP1879655A2 Pharmaceutical composition comprising an anti-bacterial agent and an activeingredient selected from carveol, thymol, eugenol, borneol and carvacrol |
| 01/23/2008 | EP1879654A2 Pharmaceutical combination comprenant un agent and an active substance selected from carveol, eugenol, thymol, borneol, carvacrol and alpha-and beta-ionones |
| 01/23/2008 | EP1879617A1 Antibody or a fragment thereof, having neutralizing activity against hiv but not against il2 |
| 01/23/2008 | EP1879610A1 Use of an immunoglobulin domain-containing cell surface recognition molecule for treating diseases |
| 01/23/2008 | EP1879589A2 Treatment and control of severe infections including cystic fibrosis |
| 01/23/2008 | EP1879575A2 Thiazole compounds and methods of use |
| 01/23/2008 | EP1725569B1 Prodrugs of piperazine and substituted piperidine antiviral agents |
| 01/23/2008 | EP1545619B1 Solution for ungual application |
| 01/23/2008 | EP1490366B1 alkoxypyridine-derivatives |
| 01/23/2008 | EP1366175B1 Multifunctional protease inhibitors and their use in treatment of disease |
| 01/23/2008 | EP1347768B1 Cosmetic and/or dermopharmaceutical preparations containing leaf extracts of the plant argania spinosa |
| 01/23/2008 | EP1339687B1 4-6-diphenyl pyridine derivatives as antiinflammatory agents |
| 01/23/2008 | EP1311261B1 Medicaments for chemotherapeutic treatment of disease |
| 01/23/2008 | EP1272514B1 Dna encoding human vanilloid receptor vr3 |
| 01/23/2008 | EP1268425B1 Carbamate caspase inhibitors and uses thereof |
| 01/23/2008 | EP1257281B8 Nucleoside analogs with carboxamidine modified monocyclic base |
| 01/23/2008 | EP1240332B1 Streptococcus pyogenes virulence genes and proteins and their use |
| 01/23/2008 | EP1240310B1 Method of inactivating microorganisms |
| 01/23/2008 | EP1220925B1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 01/23/2008 | EP1196404B1 Piperazine derivatives as modulators of chemokine receptor activity |
| 01/23/2008 | EP1141315B1 Modified hiv env polypeptides |
| 01/23/2008 | EP1140998B1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 01/23/2008 | CN101111599A Expression carrier used for treating bacterial infection |
| 01/23/2008 | CN101111513A Glycopeptide antibiotic monomer derivative |
| 01/23/2008 | CN101111498A Cefcapene pivoxil methanesulfonate |
| 01/23/2008 | CN101111475A 抗病毒化合物及方法 Antiviral compounds and methods |
| 01/23/2008 | CN101111247A Preventive or therapeutic agent for herpesvirus-related disease |
| 01/23/2008 | CN101111227A Method for production of bioresorbable microparticles microparticles thus obtained and use thereof |
| 01/23/2008 | CN101109013A Micromolecule nucleotide DNA adaptorprotein against tubercle bacillus infection and method of preparing the same |
| 01/23/2008 | CN101108882A Fusion protein of HIV regulatory/accessory proteins |
| 01/23/2008 | CN101108877A Nucleic acids and proteins from streptococcus pneumoniae |
| 01/23/2008 | CN101108872A Plants natural base extractive and formulated product and use thereof |
| 01/23/2008 | CN101108870A Process for preparation of nucleoside phosphoric acid ester compound and application thereof |
| 01/23/2008 | CN101108866A Method of preparing tilmicosin |
| 01/23/2008 | CN101108857A Nonsolvent cefozopran sodium crystallinity crystallization and method of preparing the same |
| 01/23/2008 | CN101108848A Furoquinoline compound and application of the same in manufacturing anti-virus medicament |
| 01/23/2008 | CN101108835A Method of manufacturing high purity hydrochloric acid sarafloxacin |
| 01/23/2008 | CN101108813A Method of manufacturing 1-(2-methoxyphenyl)-3-naphthyl group-2-urea |
| 01/23/2008 | CN101108250A Mono- and disaccharide derivatives |
| 01/23/2008 | CN101108247A Vibrio anguillarum exuviae vaccine and method of preparing the same |
| 01/23/2008 | CN101108237A Medicament composition for treating hepatopathy and method of preparing the same and quality control method thereof |
| 01/23/2008 | CN101108232A Externally used medicaments for treating rabies |
| 01/23/2008 | CN101108220A Medicine for treating hepatitis |
| 01/23/2008 | CN101108209A Traditional Chinese medicine for treating beriberi |
| 01/23/2008 | CN101108208A Forsythol oral preparation |
| 01/23/2008 | CN101108201A Phenolic glycosides composition of starwort undersaturation polyoses and antiviral application method of preparing the same |
| 01/23/2008 | CN101108200A Composition of starwort sulphonic acid or vitriolic acid polyoses ester total phenolic glycoside and method of preparing the same and antiviral application |
| 01/23/2008 | CN101108191A Application of a compound in preparing anti-virus medicament |
| 01/23/2008 | CN101108187A Application of a compound in preparing anti-virus medicament |
| 01/23/2008 | CN101108186A Application of a compound in preparing anti-virus medicament |
| 01/23/2008 | CN101108184A Liranaftate complex medicament and method of preparing the same |
| 01/23/2008 | CN101108183A Application of cyclophilin A restrainer in preparing anti-virus medicament |
| 01/23/2008 | CN101108179A Legalon pharmaceutical preparation and method for preparing the same |
| 01/23/2008 | CN101108178A Application of cyclophilin A restrainer in preparing anti-virus medicament |
| 01/23/2008 | CN101108177A Application of a compound in preparing anti-virus medicament |
| 01/23/2008 | CN101108169A Penciclovir freeze dried and method of manufacturing the same |
| 01/23/2008 | CN101108164A Bcg polyoses nucleic acid intralipid and its cryochem formulated product and use thereof |